Xvivo Perfusion AB (XVIVO) — Cash Flow Quality Index
Xvivo Perfusion AB (XVIVO) has a Cash Flow Quality Index of 3.90x as of June 2026. Operating cash flow of Skr63.49 Million exceeds net income of Skr16.28 Million, indicating high earnings quality where cash backs reported profits. Explore Xvivo Perfusion AB (XVIVO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xvivo Perfusion AB Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Xvivo Perfusion AB across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see XVIVO cash generation efficiency.
Annual Cash Flow Quality Index for Xvivo Perfusion AB (2012–2025)
Year-by-year earnings quality comparison for Xvivo Perfusion AB.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.02x | Skr101.07 Million | Skr25.16 Million | ▲ +621.6% |
| 2024 | 0.56x | Skr111.29 Million | Skr199.95 Million | ▲ +10.4% |
| 2023 | 0.50x | Skr46.29 Million | Skr91.82 Million | ▼ -59.6% |
| 2022 | 1.25x | Skr27.86 Million | Skr22.31 Million | ▲ +169.0% |
| 2021 | -1.81x | Skr-12.06 Million | Skr6.67 Million | ▼ -132.4% |
| 2019 | 5.58x | Skr29.50 Million | Skr5.29 Million | ▲ +313.0% |
| 2018 | 1.35x | Skr23.63 Million | Skr17.50 Million | ▼ -54.7% |
| 2017 | 2.98x | Skr22.19 Million | Skr7.45 Million | ▼ -29.0% |
| 2016 | 4.19x | Skr12.55 Million | Skr2.99 Million | ▲ +261.6% |
| 2015 | 1.16x | Skr8.58 Million | Skr7.40 Million | ▲ +308.2% |
| 2014 | -0.56x | Skr-3.74 Million | Skr6.72 Million | ▼ -144.3% |
| 2013 | 1.26x | Skr13.46 Million | Skr10.72 Million | ▼ -89.5% |
| 2012 | 12.01x | Skr1.67 Million | Skr139.00K | — |